Valneva Announces Supervisory Board Changes
Saint-Herblain (France), March 13, 2021 – Valneva SE (“Valneva”), a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, today announced that MVM …